What's New

Last Posted: Mar 30, 2023

• A Double Whammy on Gastric Cancer Risk.
  Anne Müller et al. The New England journal of medicine 2023 3 (13) 1225-1229
• Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.
  Fionnuala Crowley et al. The oncologist 2023
• Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital.
  Lauren G Santos et al. JAMA network open 2023 6(3) e231723
• Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study.
  Hiroo Fujitani et al. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023
• Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich Molecular Tumor Board.
  Klara Dorman et al. Targeted oncology 2023
• Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes.
  Derk C F Klatte et al. Preventive medicine reports 2023 31102110
• Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.
  Guettchina Telisnor et al. Journal of the National Medical Association 2023
• The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial.
  Lynette Hammond Gerido et al. Trials 2023 24(1) 105
• Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.
  Takuo Yamai et al. Cancers 2023 15(3)
• Characteristics of familial pancreatic cancer families with additional colorectal carcinoma.
  Bettina Lehman et al. Familial cancer 2023
• Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.
  Francesca Tavano et al. Molecular medicine (Cambridge, Mass.) 2023 29(1) 14
• Artificial intelligence in pancreatic cancer: diagnosis, limitations, and the future prospects-a narrative review.
  Maanya Rajasree Katta et al. Journal of cancer research and clinical oncology 2023
• Evaluation of deep learning based implanted fiducial markers tracking in pancreatic cancer patients.
  Abdella M Ahmed et al. Biomedical physics & engineering express 2023
• FAMILIAL PANCREATIC CANCER.
  Nero Lorenzo Del et al. Clinics and research in hepatology and gastroenterology 2023 102079
• Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer
  JH Stickler et al, NEJM, December 21, 2022
• Pancreatic Cancer: Beyond Brca Mutations
  V Ricci et al, J Per Med, December 16, 2022
• Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.
  Badheeb Mohamed et al. Current oncology (Toronto, Ont.) 2022 29(11) 8693-8719
• Association Between Family History and Risk of Pancreatic Cancer in Patients With BRCA1 and BRCA2 Pathogenic Variants.
  Shah Ishani et al. Pancreas 2022 51(7) 733-738
• Targeting KRAS in Pancreatic Cancer
  D Cowser et al, J Per Med, November 8, 2022
• Derivation and External Validation of Machine Learning-based Model for Detection of Pancreatic Cancer.
  Chen Wansu et al. The American journal of gastroenterology 2022

More